"Graft vs Host Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
Descriptor ID |
D006086
|
MeSH Number(s) |
C20.452
|
Concept/Terms |
Graft vs Host Disease- Graft vs Host Disease
- Graft-Versus-Host Disease
- Disease, Graft-Versus-Host
- Diseases, Graft-Versus-Host
- Graft Versus Host Disease
- Graft-Versus-Host Diseases
- Runt Disease
- Disease, Runt
- Graft-vs-Host Disease
- Disease, Graft-vs-Host
- Diseases, Graft-vs-Host
- Graft-vs-Host Diseases
- Homologous Wasting Disease
- Disease, Homologous Wasting
|
Below are MeSH descriptors whose meaning is more general than "Graft vs Host Disease".
Below are MeSH descriptors whose meaning is more specific than "Graft vs Host Disease".
This graph shows the total number of publications written about "Graft vs Host Disease" by people in this website by year, and whether "Graft vs Host Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 6 | 7 | 13 |
1995 | 4 | 8 | 12 |
1996 | 5 | 10 | 15 |
1997 | 4 | 7 | 11 |
1998 | 2 | 4 | 6 |
1999 | 5 | 12 | 17 |
2000 | 8 | 12 | 20 |
2001 | 4 | 10 | 14 |
2002 | 6 | 2 | 8 |
2003 | 4 | 14 | 18 |
2004 | 8 | 18 | 26 |
2005 | 8 | 14 | 22 |
2006 | 23 | 10 | 33 |
2007 | 14 | 17 | 31 |
2008 | 7 | 10 | 17 |
2009 | 18 | 8 | 26 |
2010 | 14 | 15 | 29 |
2011 | 19 | 23 | 42 |
2012 | 22 | 16 | 38 |
2013 | 14 | 7 | 21 |
2014 | 19 | 14 | 33 |
2015 | 19 | 19 | 38 |
2016 | 13 | 18 | 31 |
2017 | 15 | 24 | 39 |
2018 | 20 | 20 | 40 |
2019 | 20 | 12 | 32 |
2020 | 26 | 6 | 32 |
2021 | 40 | 6 | 46 |
2022 | 46 | 1 | 47 |
2023 | 28 | 0 | 28 |
2024 | 7 | 0 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Graft vs Host Disease" by people in Profiles.
-
Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation. Blood Adv. 2024 Mar 12; 8(5):1128-1136.
-
Autophagy differentially regulates tissue tolerance of distinct target organs in graft-versus-host disease models. J Clin Invest. 2024 Mar 01; 134(5).
-
Inpatient Rehabilitation of Hematopoietic Stem Cell Transplant Patients: Managing Challenging Impairments and Medical Fragility. Am J Phys Med Rehabil. 2024 Mar 01; 103(3S Suppl 1):S46-S51.
-
Gamma delta T cells in acute myeloid leukemia: biology and emerging therapeutic strategies. J Immunother Cancer. 2024 Feb 27; 12(2).
-
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. Am J Hematol. 2024 Apr; 99(4):785-788.
-
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study. Am J Hematol. 2024 Apr; 99(4):562-569.
-
Patient-reported treatment response in chronic graft-versus-host disease. Haematologica. 2024 Jan 01; 109(1):143-150.
-
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study. Bone Marrow Transplant. 2024 Mar; 59(3):334-343.
-
Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD. Blood. 2023 12 14; 142(24):2105-2118.
-
Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia. Transplant Cell Ther. 2024 Feb; 30(2):217-227.